The Brain Watch Coalition has selected DigiCARE Realized as the launch partner for an international demonstration project. The project will support adopting clinical decision applications derived from artificial intelligence/machine learning (AI/ML). The goal is to assist doctors in identifying potential cases of cognitive impairment and dementia promptly, which will enhance patient care. This project targets a launch in the third quarter of 2023.
Launching in North America, the demonstration effort will utilize DigiCARE Realized’s flagship clinical decision intelligence applications for early detection of cognitive impairment and diseases like Alzheimer’s, Lewy body dementia, Frontotemporal dementia, Vascular dementia, Parkinson’s disease dementia, and other degenerative dementias. DigiCARE Realized’s AI-powered early detection technology was developed at Indiana University and demonstrated nearly 80 percent performance accuracy with a one-year prediction horizon. Peer-reviewed papers discussing the results have been published in the Journal of the American Geriatrics Society and the Journal of Artificial Intelligence in Medicine.
“There is a growing need to routinely detect and manage the cognitive impairment associated with Alzheimer’s disease and related disorders, and exciting opportunities to help in this endeavor using emerging AI/ML, EMR, and related tools,” said Dr. Eric Reiman, Chief Executive Officer of Banner Research and Executive Director at Banner Alzheimer’s Institute. “I’m eager to learn what participants in the Brain Watch Coalition can do to help in these endeavors.”
The Brain Watch Coalition is a global partnership that aims to ensure everyone has access to affordable and accurate brain health care and treatments that promote vitality, autonomy, and independence. This international demonstration project evaluates artificial intelligence/machine learning-driven solutions from diverse healthcare systems. The initiative addresses challenges in preserving brain health within historically underserved and underrepresented communities.
“The delivery of quality, rapid, and dependable clinical care for those at higher risk or with cognitive difficulties is a key public health priority,” said Dr. Ara Khachaturian, Executive Vice President of Campaign to Prevent Alzheimer’s Disease and founder of the Brain Watch Coalition.
“The advancements in healthcare bioinformatics, we can implement these machine learning algorithms to better support care in brain health. The Brain Watch Coalition intends to accelerate the healthcare implementation plans to support clinical use in daily practice.”
The project, known as the International Demonstration for the Detection of Unrecognized Cognitive Impairment, Alzheimer’s Disease, and Related Disorders, will produce real-world evidence for health systems. Health system providers and administrators can evaluate artificial intelligence/machine learning-derived solutions regarding the accuracy of derived clinical knowledge, cost-effectiveness, and trust among healthcare personnel and patients.
The collaboration brings together stakeholders from research, education, clinical care, policy, advocacy, technology, and other healthcare service delivery partners to come together and explore the potential of these products to promote global brain health.
“The design of this first demonstration program offers the opportunity to bring experts together to build a trusted and reproducible blueprint for health system implementation so we can modernize care in complex brain disease with these advancements in AI in a responsible and impactful manner,” said Brittany Cassin, Chief Executive Officer, and co-founder of DigiCARE Realized. The DigiCARE Realized founding team also includes Drs. Malaz Boustani and Zina Ben Miled. “The team at DigiCARE Realized is proud to be part of the Brain Watch Coalition and to showcase our innovative approach for health systems to deliver routine brain care that is actually feasible to implement across their network,” said Boustani.
In addition, Khachaturian said the demonstration of various detection technologies would provide population-level specific data on how clinical decision intelligence applications may help identify cognitive decline more efficiently and among different populations while providing a comprehensive view into individual patient care decisions. The effort will also enable all stakeholders to make better-informed decisions about patient care based on real-time data analysis.
“By collaborating with DigiCARE Realized and other technology partners, the Brain Watch Coalition aims to accelerate adoption among various sectors and create an environment where innovative solutions can be validated, verified, and ultimately accredited,” Khachaturian said. “The goal is to use this demonstration platform for all stakeholders involved in brain health initiatives to come together and work towards improving brain health outcomes globally.”
About the Brain Watch Coalition, sponsored by the Campaign to Prevent Alzheimer’s Disease
The Brain Watch Coalition integrates experts under PAD20|20, a Maryland-based non-profit, tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. Brain Watch Coalition’s composition, organization, and operation will be international and virtual. Brain Watch Coalition commits to building a better world through brain health as a collaborative not-for-profit independent international project. The Coalition seeks to develop and deliver high-quality, coordinated brain health care by addressing the ongoing problems of unrecognized cognitive impairment, dementia, and other brain aging disorders. More information can be found at www.brainwatchcoalition.org or contact us at email@example.com.
The Campaign to Prevent Alzheimer’s Disease (PAD 20|20) is unlike other non-profits and academic institutions. The organization seeks solutions for the most formidable challenges to curing and caring for cognitive impairment, dementia, and other brain disorders. Using a vast global network, the organization excels at mobilizing and engaging a network of key international opinion leaders from government, academia, industry, and advocacy groups to transform strategic plans into real-world solutions. More remarkably, since 2009, PAD 20|20’s leading-edge workgroups, teams, and projects have helped spur public and private research investment for dementia and brain aging to over $10 billion in North America, Europe, and Asia.
About DigiCARE Realized Inc.DigiCARE Realized is an emerging artificial intelligence health technology firm seeking to commercialize evidence-based solutions to modernize care for complex brain diseases through decision intelligence in early detection and care management. Our initial focus is on Alzheimer’s disease and related dementia, where we seek to realize equitable, accessible, and patient-centered care. We collaborate with health systems to deliver routine brain care for our growing, aging population through our AI-enabled platform. DigiCARE Realized is a virtual-first company founded on technology developed at Indiana University. Learn more at digicarerealized.com or contact us at firstname.lastname@example.org.